Back

Flinders University Study Highlights Global Data on Rare Eye Cancer

lite News Desk 1 min read

At a glance

  • Flinders University researchers released new global findings
  • Data comes from the International Vitreoretinal B-Cell Lymphoma Registry
  • Vitreoretinal lymphoma often resembles eye inflammation, causing delays in diagnosis

Researchers at Flinders University have published global results from the International Vitreoretinal B-Cell Lymphoma Registry, providing new insights into a rare form of eye cancer.

The findings, published in Clinical & Experimental Ophthalmology, address knowledge gaps about vitreoretinal lymphoma, a cancer that begins inside the eye and is frequently misdiagnosed due to its similarity to inflammatory eye conditions.

Vitreoretinal lymphoma can be challenging to identify promptly because its symptoms often mimic those of common eye inflammations. This resemblance can result in delayed diagnosis and treatment, which may lead to permanent vision loss.

According to the research, delays in identifying this cancer are also frequently linked with the presence of lymphoma in the brain, highlighting the importance of timely recognition and intervention.

What the numbers show

  • The International Vitreoretinal B-Cell Lymphoma Registry is the largest project of its kind
  • Study findings were published in 2026
  • Research was released in the journal Clinical & Experimental Ophthalmology

Earlier diagnosis of vitreoretinal lymphoma, as documented by the registry, can help preserve vision, reduce patient distress, and prompt urgent evaluation for possible brain involvement.

The registry enables researchers to examine cases from multiple countries, offering a broader perspective on the disease's presentation and outcomes across different populations.

Professor Justine Smith, who serves as the corresponding author and is an ophthalmologist at Flinders University, stated that the international registry provides an unprecedented opportunity to study this rare cancer across continents.

By gathering and analyzing data from around the world, the registry aims to support improvements in the recognition and management of vitreoretinal lymphoma, helping clinicians respond more effectively to this rare but serious condition.

* This article is based on publicly available information at the time of writing.

Sources and further reading

Note: This section is not provided in the feeds.

Related Articles

  1. A WHO report estimates 7.1 million new cancer cases in 2022 were preventable, with tobacco smoking accounting for 15% of these cases globally.

  2. Researchers identified gut bacteria CAG-170, prevalent in healthy individuals, from over 11,000 samples across 39 countries, according to the study.

  3. Participation in US cancer clinical trials is under 10%. Nurse navigator programs have increased enrollment rates, according to reports.

  4. A trial studies tampon-based sampling for ovarian cancer detection. Researchers aim to identify tumor markers, according to the study.

  5. Illegal wildlife trade is valued between €6.6 and €21.9 billion annually, according to reports. Detection technologies are increasingly utilized.

More on Health

  1. Data from over 272,000 adults indicates nighttime road noise exceeding 50 dB is linked to changes in cholesterol markers, according to researchers.

  2. Urban planning must enhance climate resilience as populations in the Global South are set to double by 2050, according to experts.

  3. Global data centres consumed 415 TWh of electricity in 2024. New UNEP guidelines aim to reduce energy and water use by June 2025.

  4. Financial fraud resulted in losses of up to $81.5 billion for older Americans in 2024, according to the FTC. Reported losses reached $2.4 billion.

  5. A licensing agreement allows access to innovative oral drug delivery technology valued at $2.1 billion, according to company statements.